New MRI dye tested against standard for kidney scans
NCT ID NCT07040865
First seen Nov 19, 2025 · Last updated May 22, 2026 · Updated 24 times
Summary
This study compares a newer MRI contrast agent, gadopiclenol, to the standard agent, gadobutrol, for imaging the kidneys and adrenal glands. About 104 adults with incidental findings on these organs will receive one of the two dyes during a single MRI session. The goal is to see if the newer agent works just as well for diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUSPECT RENAL AND ADRENAL IMAGING FINDINGS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Diagnostic, Interventional and Pediatric Radiology Inselspital, University of Bern
RECRUITINGBern, 3010, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.